Aprogen Biologics Market Cap

Aprogen Biologics has a market cap or net worth of 200.90 billion as of June 27, 2025. Its market cap has increased by 144.43% in one year.

Market Cap

200.90B

Enterprise Value

316.03B

Revenue

68.62B

Ranking

n/a

PE Ratio

n/a

Stock Price

655.00

Market Cap Chart

Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 200.90B, an increase of 6,216.50%. That is a compound annual growth rate of 15.09%.

Market Cap History

Date	Market Cap	% Change
Jun 27, 2025	200.90B	53.60%
Dec 30, 2024	130.79B	-31.41%
Dec 28, 2023	190.68B	-4.89%
Dec 29, 2022	200.48B	-44.42%
Dec 30, 2021	360.71B	-31.18%
Dec 30, 2020	524.12B	60.07%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	71.10T
Celltrion	35.38T
ALTEOGEN	20.57T
Yuhan	7,588.59B
SK Biopharmaceuticals	7,196.99B
HLB Co., Ltd.	6,283.13B
PharmaResearch	5,189.63B
Peptron	4,822.55B

Market Cap Rankings